Expert-Guided Early Tracheostomy Pathway

NACompletedINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

January 2, 2018

Primary Completion Date

December 30, 2020

Study Completion Date

September 30, 2022

Conditions
Respiratory FailureTracheostomy Complication
Interventions
OTHER

Expert-Guided Early Tracheostomy

Patients judged to be at moderate to high risk of prolonged ventilation(26, 27) were those who had chronic respiratory failure, advanced Effectiveness of an Expert-Guided Early Tracheostomy Pathway Page 6/27 age, thrombocytopenia or coagulopathy, persistent vasopressor shock, requirement for renal replacement therapy, an admission trauma diagnosis amongst other criteria, were included. In the absence of these criteria, a consensus for low risk of prolonged MV was reached. Early PDT, within the first 7 days from intubation, was recommended for patients with a moderate/high risk of prolonged MV (Early Group). Continued MV by ETT was recommend for low-risk patients with the potential for delayed PDT in the event of delayed weaning and liberation (Late Group).

Trial Locations (1)

Unknown

King Hussein Medical Center, Amman

All Listed Sponsors
collaborator

Denver Health Medical Center

OTHER

lead

Denver Health and Hospital Authority

OTHER

NCT05595707 - Expert-Guided Early Tracheostomy Pathway | Biotech Hunter | Biotech Hunter